Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jan 22;25:101339. doi: 10.1016/j.ajoc.2022.101339

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 The Authors. Published by Elsevier Inc.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

PMC Copyright notice

Fig. 1 — Optical Coherence Tomography Images of Right and Left Eyes Over Time. Legend: Progression of optical coherence tomography (OCT) images is shown with respect to treatment changes. Day 0 (a), OCT shows presence of vitreomacular traction (VMT), cystoid macular edema (CME), and epiretinal membrane in right eye (OD) and partial vitreous detachment without CME in left eye (OS). Day 119 (c), started on difluprednate and bromfenac (BID). Day 154 (d), switched to difluprednate and nepafenac (QID), OCT shows development of cystoid macular edema (CME) (OS). Day 161 (e), stopped anastrozole. Day 210 (g), OCT shows release of vitreomacular traction (OD) and resolution of CME (OS).